Toward a Shared Vision for Cancer Genomic Data
Open accessThe DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Abstract
This FAIRsharing record describes: The National Cancer Institute’s (NCI’s) Genomic Data Commons (GDC) is a data sharing The National Cancer Institute's Genomic Data Commons (GDC) was created to promote precision medicine in oncology. It supports the import and standardization of genomic and clinical data from cancer research programs. The GDC contains NCI-generated data from some of the largest and most comprehensive cancer genomic datasets, including The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research to Generate Effective Therapies (TARGET). For the first time, these datasets have been harmonized using a common set of bioinformatics pipelines, so that the data can be directly compared. As a growing knowledge system for cancer, the GDC also enables researchers to submit data, and harmonizes these data for import into the GDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationSharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · JAMA · doi:10.1001/jama.2015.18164 · Cited by 254
Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejme1515172 · Cited by 190
Cited by
Items 201–300 of 1,004
Jiang, J., Adams, H.-P., Yao, L., Yaung, S. J., Lal, P. G., Balasubramanyam, A., Fuhlbrück, F., Tikoo, N., Lovejoy, A. F., Froehler, S., et al. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.10.013 · Cited by 65
Combined burden and functional impact tests for cancer driver discovery using DriverPower
Shuai, S., PCAWG Drivers and Functional Interpretation Working Group, Abascal, F., Amin, S. B., Bader, G. D., Bandopadhayay, P., Barenboim, J., Beroukhim, R., Bertl, J., Boroevich, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13929-1 · Cited by 59
Must-have Qualities of Clinical Research on Artificial Intelligence and Machine Learning
Koçak, B., Cuocolo, R., Santos, D. P. D., Stanzione, A., & Ugga, L. (2023) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2022.2022-11-51 · Cited by 64
DiMarco, A. V., Qin, X., McKinney, B. J., Garcia, N. M. G., Alsten, S. C. V., Mendes, E. A., Force, J. M., Hanks, B. A., Troester, M. A., Owzar, K., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0146 · Cited by 64
RETRACTED ARTICLE: Predicting cancer prognosis and drug response from the tumor microbiome
Hermida, L. C., Gertz, E. M., & Ruppin, E. (2022) · Nature Communications · doi:10.1038/s41467-022-30512-3 · Cited by 64
“Our central research questions then were, (1) does a datadriven ML approach reveal that tumor microbial abundances in TCGA data, quantified from these reads, are predictive of cancer prognosis or drug response, (2) what microbial genera are potentially predictive biomarkers of prognosis or drug response, (3) how do th…”
MethodInfluentialRetractedLuebeck, E., Curtius, K., Hazelton, W., Maden, S. K., Yu, M., Thota, P., Patil, D., Chak, A., Willis, J., & Grady, W. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0409-4 · Cited by 25
“Additional validation data, including HM450 array methylation and Illumina HiSeq 2000 RNA Sequencing data from the Version 2 analysis pipeline, were obtained for samples provided by the Cancer Genome Atlas (TCGA) via the NCI Genomic Data Commons [37] and the Firehose resource hosted by the Broad Institute (http://gdac.”
Žvirblytė, J., Nainys, J., Juzėnas, S., Goda, K., Kubiliūtė, R., Dasevičius, D., Kinčius, M., Ulys, A., Jarmalaitė, S., & Mažutis, L. (2024) · Communications Biology · doi:10.1038/s42003-024-06478-x · Cited by 64
“TCGAKIRC cohortbulk RNA-seq(upperquartileFPKMnormalized) and clinical data were downloaded from the NCI GDC Data Portal 76 using the TCGAbiolinks R package 77 .”
Functional Analysis of Cancer-Associated DNA Polymerase ε Variants inSaccharomyces cerevisiae
Barbari, S. R., Kane, D. P., Moore, E. A., & Shcherbakova, P. V. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200042 · Cited by 63
“POLE mutations have also been observed, although less frequently, in other types of gastrointestinal cancer, as well as tumors of the brain, breast, ovary, prostate, lung, kidney, cervix, and bone (Cerami et al. 2012; Forbes et al. 2015; Grossman et al. 2016; Campbell et al. 2017).”
Berkel, Ç., & Çaçan, E. (2021) · Inflammation · doi:10.1007/s10753-021-01493-0 · Cited by 64
Zeng, L., Fan, X., Wang, X., Deng, H., Zhang, K., Zhang, X., He, S., Li, N., Han, Q., & Liu, Z. (2019) · Current Genomics · doi:10.2174/1389202920666191011092410 · Cited by 62
“We downloaded the data of HCC patients’ clinical information from TCGA (The Cancer Genome Atlas) database [16] (https://cancergenome.”
MethodDirectional integration and pathway enrichment analysis for multi-omics data
Slobodyanyuk, M., Bahcheli, A. T., Klein, Z. P., Bayati, M., Strug, L. J., & Reimand, J. (2024) · Nature Communications · doi:10.1038/s41467-024-49986-4 · Cited by 62
Increased temperatures reduce the vectorial capacity of Aedes mosquitoes for Zika virus
Onyango, M. G., Bialosuknia, S. M., Payne, A. F., Mathias, N., Kuo, L., Vigneron, A., DeGennaro, M., Ciota, A. T., & Kramer, L. D. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1707125 · Cited by 61
Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer
Waks, A. G., Kim, D., Jain, E., Snow, C., Kirkner, G. J., Rosenberg, S. M., Oh, C., Poorvu, P. D., Ruddy, K. J., Tamimi, R. M., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2572 · Cited by 60
Mall, R., Bynigeri, R. R., Karki, R., Malireddi, R. K. S., Sharma, B. R., & Kanneganti, T. (2022) · NAR Cancer · doi:10.1093/narcan/zcac033 · Cited by 60
“In this study, we developed a systematic framework using 32 tumor lineages from The Cancer Genome Atlas (TCGA) (30) to characterize the prognostic implications of PANop-tosis gene expression.”
InfluentialSATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer
Ma, C., Olevian, D. C., Miller, C., Herbst, C., Jayachandran, P., Kozak, M. M., Chang, D. T., & Pai, R. K. (2019) · Modern Pathology · doi:10.1038/s41379-019-0265-1 · Cited by 60
Kim, S. Y., Jeong, S., Lee, W., Jeon, Y., Kim, Y.-J., Park, S., Lee, D., Go, D., Song, S., Lee, S., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01119-5 · Cited by 61
Hanna, G. J., Woo, S. B., Li, Y. Y., Barletta, J. A., Hammerman, P. S., & Lorch, J. H. (2017) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2017.09.006 · Cited by 61
Chen, W. S., Bindra, R. S., Mo, A., Hayman, T. J., Husain, Z. A., Contessa, J. N., Gaffney, S. G., Townsend, J. P., & Yu, J. B. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00095 · Cited by 59
“Clinical data were obtained from the TCGA Genomic Data Commons (16).”
MethodHua, T. N. M., Kim, M. K., Vo, V. T. A., Choi, J.-W., Choi, J. H., Kim, H.-W., Cha, S., Park, K., & Jeong, Y. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.015 · Cited by 59
Jurmeister, P. S., Schöler, A., Arnold, A., Klauschen, F., Lenze, D., Hummel, M., Schweizer, L., Bläker, H., Pfitzner, B. M., Mamlouk, S., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0207-y · Cited by 59
Artificial intelligence generated content (AIGC) in medicine: A narrative review
Shao, L., Chen, B., Zhang, Z., Zhang, Z., & Chen, X. (2024) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2024073 · Cited by 58
Building Flexible, Scalable, and Machine Learning-Ready Multimodal Oncology Datasets
Tripathi, A. G., Waqas, A., Venkatesan, K., Yılmaz, Y., & Rasool, G. (2024) · Sensors · doi:10.3390/s24051634 · Cited by 58
Sharing Clinical and Genomic Data on Cancer — The Need for Global Solutions
The Clinical Cancer Genome Task Team of the Global Alliance for Genomics and Health (2017) · New England Journal of Medicine · doi:10.1056/nejmp1612254 · Cited by 58
PRDM4 mediates YAP‐induced cell invasion by activating leukocyte‐specific integrin β2 expression
Liu, H., Dai, X., Cao, X., Yan, H., Ji, X., Zhang, H., Shen, S., Si, Y., Zhang, H., Chen, J., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745180 · Cited by 58
“Prostate cancer RNA-seq data from TCGA were downloaded from the Genomic Data Commons [67].”
Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy
Su, J., Song, Q., Qasem, S. A., O’Neill, S. S., Lee, J., Furdui, C. M., Pasche, B., Metheny‐Barlow, L. J., Masters, A. H., Lo, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615472 · Cited by 57
“RNA-Seq analysis was performed following the standard pipeline (20) established by The Cancer Genome Atlas (TCGA) and the National Cancer Institute Genomic Data Commons (GDC) (21, 22).”
MethodZhou, Q., Ernst, P., Morgan, K. L., Rubin, D. B., & Zhang, A. R. (2018) · Biometrika · doi:10.1093/biomet/asy031 · Cited by 55
Poulos, R. C., Wong, Y. T., Ryan, R., Pang, H., & Wong, J. W. H. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007779 · Cited by 58
Stevens, J. R., Herrick, J. S., Wolff, R. K., & Slattery, M. L. (2018) · BMC Genomics · doi:10.1186/s12864-018-5236-2 · Cited by 57
Jung, M., Lee, K., Im, Y., Seok, S. H., Chung, H., Kim, D.-Y., Han, D., Lee, C. H., Hwang, E. H., Park, S. Y., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13209 · Cited by 56
Pan‐cancer clinical and molecular analysis of racial disparities
Lara, O. D., Wang, Y., Asare, A., Xu, T., Chiu, H., Liu, Y., Hu, W., Sumazin, P., Uppal, S., Zhang, L., et al. (2019) · Cancer · doi:10.1002/cncr.32598 · Cited by 55
“These survival data were paired with molecular data from The Cancer Genome Atlas (TCGA).(19) To define the AA and EA patient groups, data from the Cancer Genome Ancestry Atlas (TCGAA)(11) were used.”
MethodGenetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer
Camiña, N., & Penning, T. M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01642-0 · Cited by 55
“There are 174 KEAP1 somatic mutations in human lung cancer [54].”
BackgroundIRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing
Pan, Y., Phillips, J. W., Zhang, B. D., Noguchi, M., Kutschera, E., McLaughlin, J., Nesterenko, P. A., Mao, Z., Bangayan, N. J., Wang, R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221116120 · Cited by 55
Liquid biopsy and its role in an advanced clinical trial for lung cancer
Johann, D. J., Steliga, M. A., Shin, I. J., Yoon, D., Arnaoutakis, K., Hutchins, L. F., Liu, M., Liem, J., Walker, K., Pereira, A., et al. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217750087 · Cited by 56
“Concerning data sharing, the Genomic Data Commons has been created by the National Cancer Institute to foster a collective vision for the sharing of cancer genomic data.(48) The AR-BIC Google Genomics Cloud follows this viewpoint.”
MethodLUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells
Jo, T., Nishikori, M., Kogure, Y., Arima, H., Sasaki, K., Sasaki, Y., Nakagawa, T., Iwai, F., Momose, S., Shiraishi, A., et al. (2020) · Blood · doi:10.1182/blood.2019002654 · Cited by 55
Clark, N. M., Martinez, L. M., Murdock, S. J., DeLigio, J. T., Olex, A. L., Effi, C., Dozmorov, M. G., & Bos, P. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108482 · Cited by 55
“TCGA Survival Analysis—Survival data for 1078 patients in the TCGA-BRCA cohort was obtained from the National Cancer Institute’s Genomic Data Commons (GDC) Data Portal (Grossman et al., 2016) exploration page on 7/9/2018.”
MethodInfluentialSelective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer
Pu, C., Tong, Y., Liu, Y., Lan, S., Wang, S., Yan, G., Zhang, H., Luo, D., Ma, X., Yu, S., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114321 · Cited by 55
Chou, P.-H., Liao, W., Tsai, K., Chen, K., Yu, J., & Chen, T.-W. (2019) · Scientific Reports · doi:10.1038/s41598-019-40629-z · Cited by 54
Fawaz, A., Ferraresi, A., & Isidoro, C. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111590 · Cited by 54
“To enable a greater understanding of cell phenotypes, massive amounts of proteome and metabolome data are being generated for various human cells [48,49].”
BackgroundKnowledge-guided analysis of "omics" data using the KnowEnG cloud platform
Blatti, C. A., Emad, A., Berry, M. J., Gatzke, L., Epstein, M., Lanier, D., Rizal, P., Ge, J., Liao, X., Sobh, O. T., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000583 · Cited by 54
“A third mode of access, created for cancer researchers, is via the Cancer Genomics Cloud resource built by Seven Bridges (SB-CGC) [7], in which users may directly access large cancer data sets, such as those generated by the Cancer Genome Atlas (TCGA) program [8], and analyze them using KnowEnG pipelines (https://cgc.”
Zottel, A., Šamec, N., Kump, A., Dall’Olio, L. R., Dominkuš, P. P., Romih, R., Hudoklin, S., Mlakar, J., Nikitin, D. M., Sorokin, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228491 · Cited by 54
“The NCH644 and NCH421k human GBM stem cell line (CLS Cell Lines Service GmbH, Eppelheim, Germany) were cultured in Neurobasal medium (Gibco) supplemented with 1% GlutaMax (Gibco), B27 supplement (Gibco), 20 ng / mL EGF (Gibco), 20 ng / mL bFGF (Gibco), 1 U / mL heparin (Sigma-Aldrich), and 1%…”
Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes
Cannataro, V. L., Mandell, J. D., & Townsend, J. P. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac084 · Cited by 56
“Indeed, the tissue of origin of this particular head-and-neck cancer was the sun-exposed lip (Grossman et al. 2016).”
Guttà, C., Rahman, A., Aura, C. M., Dynoodt, P., Charles, E. M., Hirschenhahn, E., Joseph, J., Wouters, J., de Chaumont, C., Rafferty, M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2309-3 · Cited by 55
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
Glaß, M., Misiak, D., Bley, N., Müller, S., Hagemann, S., Busch, B., Rausch, A., & Hüttelmaier, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.632219 · Cited by 53
“…additional cancer hallmark pathways, including MYC/MYCN-driven gene expression demonstrated in ovarian cancer (Köbel et al., 2007), liver cancer (Gutschner et al., 2014; Huang H. et al., 2018) and neuroblastoma (Bell et al., 2015), as well as KRAS-driven signaling in lung adenocarcinoma…”
BackgroundInfluentialKhadirnaikar, S., Shukla, S. K., & Prasanna, S. R. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-31426-w · Cited by 54
HONeYBEE: enabling scalable multimodal AI in oncology through foundation model-driven embeddings
Tripathi, A. G., Waqas, A., Schabath, M. B., Yılmaz, Y., & Rasool, G. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02003-4 · Cited by 55
CCRK is a novel signalling hub exploitable in cancer immunotherapy
Mok, M. T. S., Zhou, J., Tang, W., Zeng, X., Oliver, A. W., Ward, S. E., & Cheng, A. S. L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.008 · Cited by 53
“According to the gene profile data in the NCI Genomic Data Commons (GDC) (Grossman et al., 2016), CCRK is susceptible to genetic mutations spanning almost the entire coding region, which cause early truncation, missense and frameshift mutations (Fig.”
Mattesen, T. B., Rasmussen, M. H., Sandoval, J., Ongen, H., Árnadóttir, S. S., Gladov, J., Martínez‐Cardús, A., de Moura, M. C., Madsen, A. H., Laurberg, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16000-6 · Cited by 52
T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy
Duan, Z., & Ho, M. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0115 · Cited by 52
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma
Tanaka, K., Kandori, S., Sakka, S., Nitta, S., Tanuma, K., Shiga, M., Nagumo, Y., Negoro, H., Kojima, T., Mathis, B. J., et al. (2021) · Oncology Reports · doi:10.3892/or.2021.8234 · Cited by 52
“Clinical and RNA‐sequencing (RNA‐seq) data of primary tumors collected from patients with RCC in The Cancer Genome Atlas (TCGA) database were downloaded from the Genomic Data Commons (GDC) Data Portal (20).”
MethodIntegrative proteomic characterization of adenocarcinoma of esophagogastric junction
Li, S., Li, Y., Xu, Z., Xu, J., Chen, G., Guan, X., Pan, G.-Z., Hu, C., Dong, J., Du, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36462-8 · Cited by 52
AI-based histopathology image analysis reveals a distinct subset of endometrial cancers
Darbandsari, A., Farahani, H., Asadi, M., Wiens, M. O., Cochrane, D. R., Mirabadi, A. K., Jamieson, A., Farnell, D., Ahmadvand, P., Douglas, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49017-2 · Cited by 52
S100A10, a novel biomarker in pancreatic ductal adenocarcinoma
Bydoun, M., Sterea, A. M., Liptay, H., Uzans, A., Huang, W., Rodrigues, G. J., Weaver, I. C. G., Gu, H., & Waisman, D. M. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12356 · Cited by 52
“S100A10 mRNA is highly expressed in pancreatic tumors and cell lines To assess the relative expression levels of the S100A10 gene in cancer, we examined S100A10 mRNA levels (RNA seq V2 RSEM) across all 33 cancer types in the genomics data commons portal of the National Cancer Institute (Grossman et al., 2016).”
MethodInfluentialKounatidou, E. E., Nakjang, S., McCracken, S. R., Dehm, S. M., Robson, C. N., Jones, D. L., & Gaughan, L. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz286 · Cited by 53
“TCGA-PRAD gene expression data were downloaded from The Genomic Data Commons (GDC) (33) legacy database and normalised.”
MethodObiedat, A., Seidel, E., Mahameed, M., Bernani, O., Tsukerman, P., Voutetakis, K., Chatziioannou, A., Mcmahon, M., Avril, T., Chevet, E., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801350rr · Cited by 51
AI approaches for the discovery and validation of drug targets
Wenteler, A., Cabrera, C., Wei, W., Neduva, V., & Barnes, M. R. (2024) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2024.4 · Cited by 53
Federated and transfer learning for cancer detection based on image analysis
Bechar, A., Medjoudj, R., Elmir, Y., Himeur, Y., & Amira, A. (2025) · Neural Computing and Applications · doi:10.1007/s00521-024-10956-y · Cited by 52
“Examples of homogeneous datasets used in TL for cancer research include The Cancer Genome Atlas (TCGA) [79], The Genomic Data Commons (GDC) [80] and The Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) [81].”
Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer
Zhan, X., Cheng, J., Huang, Z., Han, Z., Helm, B. R., Liu, X., Zhang, J., Wang, T., Ni, D., & Huang, K. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001232 · Cited by 52
“TCGA aggregates an extensive collection of omics and clinical datasets from large cohorts of patients for more than 30 types of cancers (24).”
BackgroundGuo, S., Lei, J., Tao, K. X., Chen, C., Yu, H., & Liu, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01325 · Cited by 51
“BRCA data were downloaded from TCGA by using GDC Data Transfer Tool (36).”
MethodTissue-guided LASSO for prediction of clinical drug response using preclinical samples
Huang, E. W., Bhope, A., Lim, J., Sinha, S., & Emad, A. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007607 · Cited by 51
RNA editing in cancer impacts mRNA abundance in immune response pathways
Chan, T. W., Fu, T., Bahn, J. H., Jun, H.-I., Lee, J., Quinones-Valdez, G., Cheng, C., & Xiao, X. G. (2020) · Genome biology · doi:10.1186/s13059-020-02171-4 · Cited by 51
Using deep learning to identify bladder cancers with FGFR‐activating mutations from histology images
Velmahos, C. S., Badgeley, M. A., & Lo, Y. (2021) · Cancer Medicine · doi:10.1002/cam4.4044 · Cited by 51
GenoSurf: metadata driven semantic search system for integrated genomic datasets
Canakoglu, A., Bernasconi, A., Colombo, A., Masseroli, M., & Ceri, S. (2019) · Database · doi:10.1093/database/baz132 · Cited by 50
“Using it, we integrated metadata from five consolidated genomic sources: The Cancer Genome Atlas (TCGA, (2)) from Genomic Data Commons (GDC, (3,4)); The Encyclopedia of DNA Elements (ENCODE, (5,6)); Roadmap Epigenomics (7); GENCODE (8); and RefSeq (9), the latter two providing reference annotation data.”
BackgroundMethodSegura‐Bayona, S., Villamor-Payà, M., Attolini, C. S., König, L. M., Sanchiz-Calvo, M., Boulton, S. J., & Stracker, T. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107983 · Cited by 50
The impact of rare germline variants on human somatic mutation processes
Vali-Pour, M., Park, S., Espinosa‐Carrasco, J., Ortiz-Martínez, D., Lehner, B., & Supek, F. (2022) · Nature Communications · doi:10.1038/s41467-022-31483-1 · Cited by 49
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium
Grossman, R., Abel, B., Angiuoli, S., Barrett, J., Bassett, D., Bramlett, K., Blumenthal, G., Carlsson, A., Cortese, R., DiGiovanna, J., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.666 · Cited by 47
“The second goal is to develop a prototype BloodPAC Data Commons and analysis cloud, which will be based in part on the open source software developed for the NCI Genomic Data Commons and Cancer Genomics Cloud Pilots.(7) Data commons and analysis clouds colocate the data, storage, and computing infrastructure with comm…”
MethodInfluentialSelf-citationSomatic selection distinguishes oncogenes and tumor suppressor genes
Chandrashekar, P. B., Ahmadinejad, N., Wang, J., Sekulić, A., Egan, J. B., Asmann, Y. W., Kumar, S., Maley, C. C., & Liu, L. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz851 · Cited by 49
Steiner, M. C., Marston, J. L., Iñiguez, L., Bendall, M. L., Chiappinelli, K. B., Nixon, D. F., & Crandall, K. A. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3975 · Cited by 49
“Paired-end RNA-seq data (Illumina) were downloaded in BAM format ( .bam) from TCGA (29) using the Genomic Data Commons (GDC) Data Transfer Tool (30).”
MethodCo-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis
Reske, J. J., Wilson, M. R., Holladay, J., Siwicki, R. A., Skalski, H. J., Harkins, S. K., Adams, M., Risinger, J. I., Hostetter, G. H., Lin, K. Y., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009986 · Cited by 51
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer
Wu, M.-F., Lin, C.-A., Yuan, T.-H., Yeh, H.-Y., Su, S.-F., Guo, C.-L., Chang, G.-C., Li, K.-C., Ho, C.-C., & Chen, H.-W. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02781-8 · Cited by 48
The genotypes and phenotypes of missense mutations in the proline domain of the p53 protein
Hoyos, D., Greenbaum, B., & Levine, A. J. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00980-7 · Cited by 48
“DATABASES OF TP53 MUTATIONS IN THE PROLINE DOMAIN Five different databases, IARC R20 (N= 21,732) [20], TCGA (N= 2764) [21], MSK-IMPACT (N= 16,244) [22], cBio-Genie (N= 17,817) [23], and COSMIC (N= 33,176) [24], with the Tp53 gene sequenced from cancers (N= 73,857 sequences) were screened for somatic Tp53 missense muta…”
BackgroundChen, X., Yang, H. T., Zhang, B. D., Phillips, J. W., Cheng, D., Rigo, F., Witte, O. N., Xing, Y., & Black, D. L. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220190120 · Cited by 48
“The TCGA RNA-seq fastq files were downloaded from GDC through their GDC Data Transfer Tool Client (Grossman et al., 2016) while the GTEx files were downloaded from dbGAP (Mailman et al., 2007) through fastq-dump from the SRA toolkit.”
MethodEarly-onset Colon Cancer Shows a Distinct Intestinal Microbiome and a Host–Microbe Interaction
Adnan, D., Trinh, J. Q., Sharma, D., Alsayid, M., & Bishehsari, F. (2023) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-23-0091 · Cited by 49
The Epigenomic Revolution in Breast Cancer
Dávalos, V., Martínez‐Cardús, A., & Esteller, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.002 · Cited by 48
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis
Saeki, K., Chang, G., Kanaya, N., Wu, X., Wang, J., Bernal, L., Ha, D., Neuhausen, S. L., & Chen, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02201-2 · Cited by 48
Yu, Y., Hou, W., Liu, Y., Wang, H., Dong, L., Mai, Y., Chen, Q., Li, Z., Sun, S., Yang, J., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01867-9 · Cited by 48
“According to ISO Guide 35 (2017) 37 , ISO/IEC Guide 93-3 (2008) 38 and SAC JJF-1343 (2012) 39 , the source of uncertainties can be classified into characterization uncertainties ( u char ), sample inhomogeneities (between-bottle variation, u bb ) and instabilities ( u s ).”
BackgroundInfluentialTissue-specific roles of de novo DNA methyltransferases
Tóth, D. M., Szeri, F., Ashaber, M., Muazu, M., Székvölgyi, L., & Arányi, T. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00566-2 · Cited by 47
Cannataro, V. L., Gaffney, S. G., Stender, C., Zhao, Z.-M., Philips, M., Greenstein, A. E., & Townsend, J. P. (2018) · Oncogene · doi:10.1038/s41388-017-0105-z · Cited by 42
Benfeitas, R., Bidkhori, G., Mukhopadhyay, B., Klevstig, M., Arif, M., Zhang, C., Lee, S., Cinar, R., Nielsen, J., Uhlen, M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.057 · Cited by 45
“Predominant expression of G6PD- andALDH2-clustered genes inmouse andhumanHCC MTHFS) using RNA-seq data for 360 patients from TCGA (left), and from an independent micro PFKP, CAT, and MTHFD1 through antibodies HPA000834, HPA001275, HPA018257, HPA055 counterstaining in blue.”
MethodInfluentialCell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
Zhou, Q. X., Perakis, S. O., Ulz, P., Mohan, S., Riedl, J. M., Talakić, E., Lax, S., Tötsch, M., Höefler, G., Bauernhofer, T., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-0719-6 · Cited by 47
RUNX3 methylation drives hypoxia-induced cell proliferation and antiapoptosis in early tumorigenesis
Lee, S. H., Hyeon, D. Y., Yoon, S.-H., Jeong, J.-H., Han, S.-M., Jang, J.-W., Nguyen, M. P., Chi, X., An, S., Hyun, K.-G., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00647-1 · Cited by 47
“For the TCGA cohort, we collected Fragment Per Kilobase of transcript per Million mapped reads (FPKMs) for 60,483 gene features for 375 stomach adenocarcinoma samples from TCGA genomic data commons (GDC) data portal [26].”
MethodMustafa, A. M., & Krämer, O. H. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000612 · Cited by 46
Bidkhori, G., Benfeitas, R., Elmas, E., Kararoudi, M. N., Arif, M., Uhlén, M., Nielsen, J., & Mardinoğlu, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00916 · Cited by 46
“Gene Expression Data and Modeling for HCC Patients Transcriptomic data (RNA-seq) for 50HCC and 50 adjacent noncancerous liver samples were retrieved from NCI’s Genome Data Commons (Grossman et al., 2016) as Fragments Per Kilobase of transcript per Million mapped reads (FPKM).”
Yu, Y., Wang, Y., Xia, Z., Zhang, X., Jin, K., Yang, J., Ren, L., Zhou, Z., Yu, D. S., Qing, T., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1042 · Cited by 46
“gov/) (25) and the Genotype-Tissue Expression (GTEx) project (https://gtexportal.”
BackgroundInsights into rheumatic diseases from next-generation sequencing
Donlin, L. T., Park, S. H., Γιαννοπούλου, Ε., Ivovic, A., Park‐Min, K., Siegel, R. M., & Ivashkiv, L. B. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0217-7 · Cited by 46
Reproducible big data science: A case study in continuous FAIRness
Madduri, R., Chard, K., D’Arcy, M., Jung, S. C., Rodriguez, A., Sulakhe, D., Deutsch, E. W., Funk, C. C., Heavner, B., Richards, M. A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213013 · Cited by 46
“In the case of the Analysis Commons [54] and 443 Genomic Data Commons [55], this environment is a (public or private) cloud.”
BackgroundHemming, M. L., Fan, C., Raut, C. P., Demetri, G. D., Armstrong, S. A., Sicińska, E., & George, S. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0197 · Cited by 46
“Data availability Previously published RNA-seq and 3SEQ data presented in this publication are available through the GEO Publication Reference IDs GSE45510 (16), GSE75885 (20), GSE87581 (21), the NCBI's Database of Genotypes and Phenotypes (18, 29), and the NCI Genomic Data Commons (5, 19).”
MethodInfluentialSimplified and Unified Access to Cancer Proteogenomic Data
Lindgren, C. M., Adams, D. W., Kimball, B., Boekweg, H., Tayler, S., Pugh, S. L., & Payne, S. H. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00919 · Cited by 40
Ebersberger, S., Hipp, C., Mulorz, M. M., Buchbender, A., Hubrich, D., Kang, H.-S., Martínez‐Lumbreras, S., Kristofori, P., Sutandy, F. X. R., Allcca, L. L., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.07.002 · Cited by 47
Yamauchi, M., Ono, A., Amioka, K., Fujii, Y., Nakahara, H., Teraoka, Y., Uchikawa, S., Fujino, H., Nakahara, T., Murakami, E., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00390-x · Cited by 45
“For validation of the clustering method based on the transcriptome, RNA sequencing data from the liver HCC cohort from The Cancer Genome Atlas (TCGA-LIHC) were downloaded from the National Cancer Institute-Genomic Data Commons Data Portal 20 .”
MethodAn immunogenetic basis for lung cancer risk
Krishna, C., Tervi, A. M., Saffern, M., Wilson, E. A., Yoo, S., Mars, N., Roudko, V., Cho, B. A., Jones, S. E., Vaninov, N., et al. (2024) · Science · doi:10.1126/science.adi3808 · Cited by 48
Tran, D., Nguyen, H., Pham, V.-D., Nguyen, T. N. P., Luu, H. N., Phan, L. M., DeStefano, C. B., Yeung, S. J., & Nguyen, T. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf150 · Cited by 45
CancerLivER: a database of liver cancer gene expression resources and biomarkers
Kaur, H., Bhalla, S., Kaur, D., & Raghava, G. P. S. (2020) · Database · doi:10.1093/database/baaa012 · Cited by 45
“…data generated from most of these high-throughput studies have been deposited over the time in various databases like Genomic Data Commons (GDC) data portal (3), International Cancer Genome Consortium (ICGC) Data Portal (4), The Cancer Genome Atlas (TCGA) (5) and Gene Expression Omnibus (GEO) (6).”
BackgroundProfilin choreographs actin and microtubules in cells and cancer
Pimm, M. L., Hotaling, J., & Henty-Ridilla, J. L. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.05.005 · Cited by 47
“AUTHOR CONTRIBUTIONS J.L.H.-R. downloaded and analyzed the transcript data from the National Cancer Institute Genomic Data Commons (https:// portal.gdc.cancer.gov; Grossman et al., 2016).”
BackgroundMethodInfluentialXiang, R., Ma, L., Yang, M., Zheng, Z., Chen, X., Jia, F., Xie, F., Zhou, Y., Li, F., Wu, K., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02007-2 · Cited by 46
Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence
Miller, C. A., Walker, J. R., Jensen, T. L., Hooper, W. F., Fulton, R. S., Painter, J. S., Sekeres, M. A., Ley, T. J., Spencer, D. H., Goll, J. B., et al. (2022) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.10.013 · Cited by 37
Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls
Buckley, A. R., Standish, K. A., Bhutani, K., Ideker, T., Lasken, R. S., Carter, H. K., Harismendy, O., & Schork, N. J. (2017) · BMC Genomics · doi:10.1186/s12864-017-3770-y · Cited by 45
“We note that since the initiation of our analysis, the raw TCGA sequence data have moved to the GDC [35].”
BackgroundMethodZheng, Y., Conrad, R. D., Green, E. J., Burks, E. J., Betke, M., Beane, J. E., & Kolachalama, V. B. (2024) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2024.3386108 · Cited by 44
“3) Genomic Signature Embeddings: Gene counts derived from bulk RNA sequencing data from LUAD (229 CPTAC; 517 TCGA) and LUSC (109 CPTAC; 501 TCGA) tumor samples were obtained from the Genomic Data Commons [16].”
MethodManske, F., Ogoniak, L., Jürgens, L., Grundmann, N., Makałowski, W., & Wethmar, K. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac899 · Cited by 44
Three-dimensional genome landscape of primary human cancers
Yost, K. E., Zhao, Y., Hung, K. L., Zhu, K., Xu, D., Corces, M. R., Shams, S., Louie, B. H., Sarmashghi, S., Sundaram, L., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02188-0 · Cited by 45
“The antibodies are validated for use on human samples on the manufacturer's websites and give highly reproducible results with published positive control data-sets including ChIP-seq data from primary tissues and ATAC-seq from matched tumor samples.”
Rapisuwon, S., Izar, B., Batenchuk, C., Avila, A., Mei, S., Sorger, P. K., Parks, J. M., Cooper, S. J., Wagner, D. H., Zeck, J. C., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0533-0 · Cited by 44
Metadata
- Authors
- Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-09-22
- Volume
- 375
- Issue
- 12
- Pages
- 1109-1112
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6309165
- OpenAlex
- W2521492299
- Cited by
- 1,680
- References
- 7
- Citations by year
- 2026: 111 · 2025: 141 · 2024: 192 · 2023: 223 · 2022: 231 · 2021: 238 · 2020: 190 · 2019: 171 · 2018: 114 · 2017: 64 · 2016: 5
- FWCI
- 49.40
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC008905)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- Genomic Data Commons, data sharing, data harmonization, precision oncology, TCGA, targets, bioinformatics pipeline, clinical data standardization, data interoperability
- MeSH terms
- DNA, Neoplasm, Humans, Neoplasms, United States, Genome, Human, National Cancer Institute (U.S.), Precision Medicine, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.